Reporting Manager
JAMES E. BESSER
Symbol
NMTC
Shares outstanding
32,312,898 shares
Disclosed Ownership
1,583,332 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 15:11:12 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"MANCHESTER MANAGEMENT CO LLC disclosed 4.9% ownership in NEUROONE MEDICAL TECHNOLOGIES CORP Common Stock, $0.001 par value (NMTC) on 31 Dec 2024."

Quick Takeaways

  • MANCHESTER MANAGEMENT CO LLC filed SCHEDULE 13G/A for NEUROONE MEDICAL TECHNOLOGIES CORP Common Stock, $0.001 par value (NMTC).
  • Disclosed ownership: 4.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 15:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
MANCHESTER EXPLORER, L.P. 4.1% 1,333,333 0 1,333,333 By: /s/ James E. Besser James E. Besser, Managing Member of the General Partner
MANCHESTER MANAGEMENT COMPANY, LLC 4.6% 1,499,999 0 1,499,999 By: /s/ James E. Besser James E. Besser, Managing Member
MANCHESTER MANAGEMENT PR, LLC 4.6% 1,499,999 0 1,499,999 By: /s/ James E. Besser James E. Besser, Managing Member
JAMES E. BESSER 4.9% 1,583,332 83,333 1,499,999 By: /s/ James E. Besser James E. Besser
MORGAN C. FRANK 4.4% 1,416,666 83,333 1,333,333 By: /s/ Morgan C. Frank Morgan C. Frank